CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $89,500
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-21 | KEATING LAURIE Director | Grant or award · Stock Option | +14,200 | 14,200 | ||
| 2022-06-21 | HAUSMAN DIANA Director | Grant or award · Stock Option | +6,185 | 6,185 | ||
| 2022-05-25 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +2,551 | $3.92 | $10K | 332,685 |
| 2022-05-17 | Bookman Michael GENERAL COUNSEL AND SECRETARY | Purchase | +1,000 | $4.88 | $5K | 2,402 |
| 2022-05-16 | KEATING LAURIE Director | Purchase | +7,000 | $5.00 | $35K | 14,000 |
| 2022-05-12 | Amin Biren CFO, TREASURER | Purchase | +1,000 | $4.42 | $4K | 7,898 |
| 2022-04-12 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion | +2,000 | $3.01 | $6K | 2,259,352 |
| 2022-04-12 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion · Stock Option | −2,000 | 206,000 | ||
| 2022-03-23 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +3,000 | $8.02 | $24K | 2,257,352 |
| 2022-03-23 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +1,050 | $7.91 | $8K | 330,134 |
| 2022-03-22 | Barrett Scott CHIEF MEDICAL OFFICER | Purchase | +900 | $7.49 | $7K | 7,563 |
| 2022-03-15 | Feinberg Peter Director | Purchase | +6,667 | $6.75 | $45K | 11,766 |
| 2022-03-15 | BERMAN ANN E Director | Purchase | +6,000 | $6.40 | $38K | 9,500 |
| 2022-02-28 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion | +2,000 | $3.01 | $6K | 2,254,352 |
| 2022-02-28 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion · Stock Option | −2,000 | 208,000 | ||
| 2022-02-10 | Amin Biren CFO, TREASURER | Grant or award · Stock Option | +70,050 | 70,050 | ||
| 2022-02-10 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +83,100 | 83,100 | ||
| 2022-02-10 | Barrett Scott CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +71,850 | 71,850 | ||
| 2022-02-10 | Bookman Michael GENERAL COUNSEL AND SECRETARY | Grant or award · Stock Option | +47,300 | 47,300 | ||
| 2022-02-10 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +156,485 | 156,485 |
Page 9 of 12 · 226 trades